CDH13 and breast carcinoma: Current studies have highlighted that a low or insufficient level of T-cadherin expression in a variety of tumor cells is often closely correlated with the malignant features, as observed in breast cancer, colorectal cancer, endometrial cancer, bladder cancer, melanoma, and squamous cell cancer (45–50).